Skip to content
HCSG

HEALTHCARE SERVICES GROUP INC

HEALTHCARE SERVICES GROUP INC Q1 FY2025 earnings call

April 23, 2025 · fiscal period ended 2025-03

EPS · actual vs est

$0.23 / $0.18Beat +27.8%

Revenue · actual vs est

$447.7M / $446.6MBeat +0.2%
Ask about this call

Summary

Generated 2025-04-23

Management highlights

Q1 Highlights: - First quarter revenue and cash flows were the best in five years, with positive momentum carrying into Q2. - New client wins drove organic growth, collections exceeded revenue, and balance sheet was strengthened. ### Industry Environment: - Industry fundamentals gaining strength due to multi-decade demographic tailwind. - Operating trends positive: workforce availability, occupancy growth, stable reimbursement. - Texas federal court struck down key provisions of CMS's minimum staffing rule, applying nationwide. ### Strategic Priorities for Q2 and Year Ahead: - Driving growth by developing management candidates, converting sales pipeline, retaining existing facilities. - Managing costs through field-based operations and prudent spend. - Optimizing cash flow with increased payment frequency, enhanced contracts, and disciplined working capital management.

View in transcript ↓

Segment performance

For the three months ended March 31st, Healthcare Services Group reported revenue of $447.7 million, a 5.7% increase over the prior year. Environmental services revenue was $196.3 million with a margin of 10.8%, and dietary services revenue was $251.3 million with a margin of 7.6%. Cost of services was $379.7 million (84.8%), and SG&A was $45 million, with adjusted SG&A at $46.4 million (10.4%).

View in transcript ↓

Guidance

  • Raised 2025 cash flow from operations expectations, excluding change in payroll accrual, from $45-$60 million to $60-$75 million. - Q2 revenue guidance: $445 to $455 million. - First quarter included a $12.2 million benefit from CARES Act-related employee retention credits. - Made a small tuck-in acquisition in March, with 2025 revenue impact about 1% of total revenue. - Repurchased approximately $7 million of common stock in Q1, with $23 million total buyback since February 2023 authorization.
View in transcript ↓

Risks

  • Regulatory uncertainties: potential provider taxes and changes in Medicaid reimbursements are too early to determine impact. - Inflation impacts on costs, particularly food and labor, with monitoring needed despite pass-through provisions in contracts. - Labor market challenges in the skilled nursing industry, though industry adding jobs and showing recovery trends.
View in transcript ↓

Q&A highlights

Q: Andrew Wittmann asked about regulatory environment changes, including potential provider taxes and Medicaid reimbursements.

A: Theodore Wahl noted industry fundamentals are strong, Texas court ruling removed staffing rule overhang, and provider taxes are too early to tell with varying impacts by provider type.

Q: A.J. Rice inquired about the court ruling's impact on staffing behavior and SG&A guidance.

A: Theodore Wahl said the ruling mainly removed overhang, not immediate staffing behavior impact; SG&A expected to be in 9.5%-10.5% range near term with long-term goal of 8.5%-9.5%.

Q: Tayo Key asked about Q2 revenue guide and cash flow raise.

A: Theodore Wahl explained Q2 guide considers acquisition and timing of new business; Vikas Singh said cash flow raise is from CARES Act benefit and strong Q1 collection momentum, with confidence in sustaining positive momentum.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.23$0.18+27.8%
Revenue$447.7M$446.6M+0.2%

Transcript

April 23, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.